Fig. 3: The combination of vesatolimod, Ad26/MVA, and PGT121 treatment resulted in the fewest viremic animals post-ART cessation. | Nature Communications

Fig. 3: The combination of vesatolimod, Ad26/MVA, and PGT121 treatment resulted in the fewest viremic animals post-ART cessation.

From: Therapeutic efficacy of combined active and passive immunization in ART-suppressed, SHIV-infected rhesus macaques

Fig. 3

Plasma SHIV viral loads from the cessation of ART to day 168 with the median viral load of each group indicated by a red line. The number and percentage of animals in each group that rebounded are indicated below the group label, and the number of animals in the group with a negative viral load at the end of the surveillance period is indicated in the lower right corner of each graph.

Back to article page